PT  - JOURNAL ARTICLE
AU  - Unalp-Arida, Aynur
AU  - Ruhl, Constance E.
TI  - Prepandemic prevalence estimates of fatty liver disease and fibrosis defined by liver elastography in the United States
AID  - 10.1101/2022.04.05.22273458
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.05.22273458
4099  - http://medrxiv.org/content/early/2022/04/06/2022.04.05.22273458.short
4100  - http://medrxiv.org/content/early/2022/04/06/2022.04.05.22273458.full
AB  - Background & Aims Fatty liver disease is a growing public health burden with serious consequences. We estimated prepandemic prevalence of fatty liver disease determined by transient elastography assessed hepatic steatosis and fibrosis, and examined associations with lifestyle and other factors in a United States population sample.Methods Liver stiffness and controlled attenuation parameter (CAP) were assessed on 7,923 non-Hispanic white, non-Hispanic black, non-Hispanic Asian, and Hispanic men and women aged 20 years and over in the National Health and Nutrition Examination Survey (NHANES) 2017-March 2020 prepandemic data.Results The prevalence of fatty liver disease estimated by CAP >300 dB/m was 28.8% and of fibrosis (liver stiffness >8 kPa) was 10.4%. Only 7.2% of participants with fatty liver disease and 10.9% with fibrosis reported being told by a health care provider that they had liver disease. In addition to known risk factors such as metabolic factors and ALT, persons with fatty liver disease were less likely to meet physical activity guidelines, more likely to be sedentary for 12 or more hours a day, and reported a less healthy diet. Persons with fibrosis were less likely to have a college degree and reported a less healthy diet.Conclusion In the U.S. population, most persons with fatty liver disease are unaware of their condition. Although physical activity and dietary modifications might reduce the fatty liver disease burden, the COVID pandemic has been less favorable for lifestyle changes. There is an urgent need for fatty liver disease management in high-risk individuals using transient elastography or other noninvasive methods to intervene in disease progression.Competing Interest StatementConflicts of interest for Dr. Unalp-Arida: The National Institute of Diabetes and Digestive and Kidney Diseases is a funding collaborator with the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS) through the United States Government Interagency Agreement (IAA) Number ADK15006 (also known as IAA# 164 at NCHS). Dr. Ruhl: No conflicts.Funding StatementFinancial Support: The work was supported by a contract from the National Institute of Diabetes and Digestive and Kidney Diseases (HHSN275201700074U).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All NHANES data used for this paper are publicly available (https://www.cdc.gov/nchs/nhanes/index.htm).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll NHANES data used for this paper are publicly available. https://www.cdc.gov/nchs/nhanes/index.htm